Medical Cannabis Significantly Safer for Elderly With Chronic Pain Than Opioids, According to Ben-Gurion University of the Negev Researchers
Medical cannabis therapy can significantly reduce chronic pain in patients age 65 and older without adverse effects, according to researchers at Ben-Gurion University of the Negev (BGU) and the Cannabis Clinical Research Institute at Soroka University Medical Center.
The new study, published in The European Journal of Internal Medicine, found cannabis therapy is safe and efficacious for elderly patients who are seeking to address cancer symptoms, Parkinson’s disease, post-traumatic stress disorder, ulcerative colitis, Crohn’s disease, multiple sclerosis, and other medical issues.
“While older patients represent a large and growing population of medical cannabis users, few studies have addressed how it affects this particular group, which also suffers from dementia, frequent falls, mobility problems, and hearing and visual impairments,” says Prof. Victor Novack, M.D., a professor of medicine in the BGU Faculty of Health Sciences (FOHS), and head of the Soroka Cannabis Clinical Research Institute. Novack is also the BGU Gussie Krupp Chair in Internal Medicine.
“After monitoring patients 65 and older for six months, we found medical cannabis treatment significantly relieves pain and improves quality of life for seniors with minimal side effects reported.”
This older population represents a growing segment of medical cannabis users, ranging from approximately seven percent to more than 33 percent, depending on the country. Recent U.S. polls indicate Americans over 65 represent 14 percent of the total population and use more than 30 percent of all prescription drugs, including highly addictive painkillers.
BGU researchers surveyed 2,736 patients 65 years and older who received medical cannabis through “Tikun Olam,” the largest Israeli medical cannabis supplier. More than 60 percent were prescribed medical cannabis due to the pain, particularly pain associated with cancer. After six months of treatment, more than 93 percent of 901 respondents reported their pain dropped from a median of eight to four on a 10-point scale. Close to 60 percent of patients who originally reported “bad” or “very bad” quality of life upgraded to “good” or “very good” after six months. More than 70 percent of patients surveyed reported moderate to significant improvement in their condition.
The most commonly reported adverse effects were dizziness (9.7 percent) and dry mouth (7.1 percent). After six months, more than 18 percent of patients surveyed had stopped using opioid analgesics or had reduced their dosage.
All patients received a prescription after consulting with a doctor who prescribed treatment. More than 33 percent of patients used cannabis-infused oil; approximately 24 percent inhaled therapy by smoking, and approximately six percent used vaporization.
While the researchers state their findings to date indicate cannabis may decrease dependence on prescription medicines, including opioids, more evidence-based data from this special, aging population is imperative.
Learn more:Â Medical cannabis significantly safer for elderly with chronic pain than opioids
The Latest on: Medical cannabis therapy
[google_news title=”” keyword=”Medical cannabis therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Medical cannabis therapy
- Thailand PM Srettha to outlaw cannabis by end of 2024, in stunning U-turn just 2 years after it was decriminalisedon May 8, 2024 at 2:26 pm
PM Srettha Thavisin has voiced his opposition to the recreational use of cannabis since taking office, arguing it could exacerbate existing drug abuse problems ...
- Calls to poison centers involving synthetic cannabis jumpon May 8, 2024 at 8:02 am
Calls to U.S. poison centers regarding so-called synthetic cannabis jumped 88% between 2021 and 2022, as use of these legally sold products rose, research shows.
- Cannabis Ages Brain By Almost 3 Years, Study Claimson May 8, 2024 at 6:08 am
Strains with high THC potency have been linked to psychosis in younger populations (1), rare addictions (2), and cannabinoid hyperemesis syndrome among frequent users (3), for example. Reefer Madness ...
- UB experts weigh in on DEA’s reclassification of cannabison May 7, 2024 at 5:00 pm
“Research has shown that components of cannabis have medical uses. The FDA has approved the CBD-based drug Epidiolex because it has been effective in the treatment of rare childhood epilepsies. There ...
- Cannabis Controls Patients' Pain While Improving Gastrointestinal And Pulmonary Function, Anesthesiologist Discusses Alternative To Opioidson May 7, 2024 at 11:27 am
" Overall, medical cannabis use supports a 30-40% reduction in opioid consumption," says Fowler. "Not only does it control patients’ pain but it is also beneficial for gastrointestinal and pulmonary ...
- Could cannabis treat cancer someday? Here's what the science says so faron May 7, 2024 at 9:03 am
For decades, cannabis has been studied for its potential antitumor properties, but whether it can actually treat cancer is still unknown.
- Medical Cannabis Program on the Decline in New Jerseyon May 7, 2024 at 7:42 am
Patient numbers are at an all-time low, and patients are facing a myriad of roadblocks, such as limited medical-only dispensaries, steep doctor’s visit fees, and more.
- Las Vegas Cannabis Powerhouse Planet 13 To Close $49M Florida Expansion Deal After Achieving Another Milestoneon May 7, 2024 at 7:24 am
Planet 13 closed its previously announced sale of Planet 13 Florida, Inc. on Monday, following the previously announced approval from the Florida Office of Medical Marijuana Use in April. The Las ...
- Medical marijuana could soon be available at your local GA pharmacyon May 6, 2024 at 2:32 pm
“We were the only state in the United States to have pharmacists be able to dispense medical marijuana,” Katz said. The DEA is in the process of downgrading the classification of marijuana from a ...
- New Jersey Medical Marijuana Program Shrinks While Recreational Market Expandson May 6, 2024 at 6:00 am
Patients are seemingly leaving the program because they cannot afford the fees they are being charged by some doctors.” By Sophie Nieto-Muñoz, New Jersey Monitor Recreational marijuana continues to ...
via Bing News